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Access to and coverage of renal replacement therapy in
minorities and ethnic groups in Venezuela. Numerous studies
have documented the presence of racial and minority dispari-
ties regarding the impact of renal disease and access to renal
replacement therapy (RRT). This problem is less well docu-
mented in Latin America. Venezuela, like most countries in
the region, is subject to severe constraints in the allocation of
resources for high-cost chronic diseases, which limits the ac-
cess of patients with chronic kidney disease to RRT. Although
access to health care is universal, there is both a deficit in cov-
erage and disparity in the access to RRT, largely as a result
of socioeconomic limitations and budget constrains. With cur-
rent rising trends of the incidence of end-stage renal disease
(ESRD) and costs of medical technology, the long-term goal of
complete RRT coverage will become increasingly out of reach.
Current evidence suggests that prevention of progression of re-
nal disease is possible at relatively low cost and broad coverage.
Based on this evidence, the Ministry of Health has redesigned
its policy with respect to renal disease based on 4 elements: 1.
Prevention by means of early detection and referral to multidis-
ciplinary health teams, as well as promotion of health habits in
the community. 2. Prevention of progression of renal disease by
pharmacologic and nonpharmacologic means. 3. An increase in
the rate of coverage and reduction of disparities in the access
to dialysis. 4. An increase in the rates of renal transplantation
through better organ procurement programs and reinforcement
of transplant centers. However, the projected increase in the
number of patients with ESKD receiving RRT will represent a
serious burden to the health care system. Therefore, implemen-
tation of these policies will require the involvement of inter-
national agencies as well as an adequate partnership between
nephrologists and health care planners, so that meeting the in-
creasing demands of ESKD programs may be balanced with
other priorities of our national health system.
Resumen
Numerosos estudios han documentado la presencia de in-
equidades entre grupos e´tnicos y minoritarios, en relacio´n al
impacto de la enfermedad renal cro´nica (ERC) y el acceso a la
terapias de reemplazo renal (TRR) en estos grupos. Estas de-
sigualdades no han sido bien documentadas en Latinoame´rica.
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Venezuela, como la mayorı´a de paı´ses en la regio´n, esta´ su-
jeta a severas limitaciones de recursos econo´micos asignados
al tratamiento de enfermedades cro´nicas de alto costo, re-
stringiendo ası´ el ingreso de pacientes renales a las TRR. A
pesar de que el acceso al sistema de salud es universal, existe
un de´ficit de cobertura y una inequidad en el acceso a las TRR,
en gran parte debido tanto a factores socioecono´micos como
presupuestarios. Con el constante incremento en la incidencia
de la ERC, ası´ como en el costo de la tecnologı´a me´dica, el ob-
jetivo de lograr una cobertura completa parece ser cada dı´a ma´s
distante. Actualmente, existen evidencias que demuestran que
la prevencio´n de la progresio´n del dan˜o renal es posible, a un
bajo costo y con una mayor cobertura. Basado en lo anterior, el
Ministerio de Salud ha redisen˜ado sus polı´ticas en relacio´n a la
ERC a partir de cuatro elementos: 1. La prevencio´n de la ERC a
trave´s de la deteccio´n oportuna y la referencia a grupos de salud
multidisciplinarios, ası´ como la promocio´n de la salud en la co-
munidad. 2. Prevencio´n del deterioro de la funcio´n renal, tanto
con medidas farmacolo´gicas como no farmacolo´gicas. 3. Incre-
mentar la cobertura y disminuir las inequidades en el acceso a
las TRR. 4. Aumentar el nu´mero de trasplantes renales a trave´s
de mejores sistemas de procuracio´n y el reforzamiento de los
programas de trasplante. Sin embargo, el incremento proyec-
tado en el nu´mero de pacientes con ERC que requerira´n TRR,
representara´ una seria presio´n al sistema de salud. Por lo an-
terior, la implementacio´n de estas polı´ticas de salud requerira´
de la participacio´n de organismos internacionales, ası´ como de
la estrecha colaboracio´n entre los nefro´logos y el Ministerio de
Salud, que permitan equilibrar la creciente demanda de servi-
cios de pacientes con ERC con otras prioridades de salud en
nuestro paı´s.
Numerous studies have documented disparities in kid-
ney disease and access to renal replacement therapy
(RRT) among ethnic minority groups. In the United
States, these disparities in the prevalence of end-stage re-
nal disease (ESRD) are more evident for African Amer-
icans, Hispanics, and Native Americans [l–5]. Although a
discussion on potential causes behind these disparities is
beyond the scope of this presentation, most investigators
agree that a wide spectrum of factors, including biologi-
cal, environmental, socioeconomic, lifestyle, and cultural
conditions may influence, to a greater or lesser degree, the
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development and/or progression of renal disease among
the different groups.
The problem of disparity in access to RRT in minor-
ity groups is less well documented in other countries of
the American Continent. However, the economic impact
and strain on human and technical resources for the care
of chronic kidney disease (CKD) and RRT are greater
on developing countries whose health care systems are
already overburdened with demands for primary care.
In Venezuela, the cost of the national dialysis program
for roughly 7500 patients is 4 times the expenditure for
the vaccination program and 20 times that of the malaria
prevention program. The prevalence of ESRD is 292 per
million population (pmp), similar to the average for Latin
American countries (278 pmp) [6], but far lower than in
the United States (1131 pmp) [2], Japan (1397 pmp), and
the European Union (644 pmp). Venezuela, like most
Latin American countries, has severe constraints in the al-
location of resources for high-cost chronic diseases, which
affect not only minorities but a great proportion of the
population. Therefore, there is severe limitation in re-
sources for RRT.
ETHNIC COMPOSITION OF SOCIETY IN
VENEZUELA
Society in Venezuela is mainly an amalgam of 3 races,
resulting in a predominant mestizo population (a mixture
of whites, blacks, and Indians). Therefore, ethnic cate-
gories can be regarded as points along a continuum rather
than as distinct categories. Physical appearance and skin
color, rather than ethnicity per se, become the major cri-
teria for classification. Approximately 52% to 82% of the
Venezuelan population is classified as mestizo, about 21%
are white, 10% are black, and only 1.5% (315,815 peo-
ple) is composed of over 25 different indigenous tribes.
The majority of the Indian groups live in communities
relatively isolated socially and geographically, and they
preserve most of their lifestyles and cultural traditions.
The Goajiro Indians are the largest tribe, compris-
ing about 60% of the total indigenous population of
Venezuela. They occupy part of the Zulia State in the bor-
der between Venezuela and Colombia. The second and
third largest groups of Venezuelan Indians, comprising
14.8% and 11% of the total, respectively, include several
communities that occupy an extended area in the south-
ern states of Amazonas and Bolivar. Most of these tribes
are dispersed in relatively small communities in rural and
jungle areas with a population density of less than 1 in-
habitant per square kilometer. Other relatively smaller
tribes are dispersed in at least 5 additional states. Com-
munication with and within the Indian communities is
limited because of great distances, lack of good roads, and
limited economic resources. These factors, together with
the deficiencies of coverage by the national health sys-
tem, result in disparities in access to medical care among
indigenous communities.
INCIDENCE AND PREVALENCE OF CKD IN
VENEZUELA
The major causes of ESRD in Venezuela are diabetic
nephropathy and hypertension, accounting for almost
50% of patients on dialysis, followed by glomerulonephri-
tis, obstructive uropathy, and tubulointerstitial nephritis
[7]. The prevalence of diabetic nephropathy has increased
progressively, reaching 27% by the year 2001. The rea-
sons for the increase are multifactorial. In Venezuela,
late referral to specialized nephrologic care likely plays
an important role. Indeed, diabetes mellitus accounts
for only 3.0% of the consultations in nephrology clin-
ics of the national hospital network, after hypertension,
glomerular diseases, CKD, urinary tract infection, and lu-
pus nephropathy. By the time patients with diabetes reach
nephrologists, they already have a moderate-to-severe
decrease in glomerular filtration rate, thus limiting the
benefits of early interventions to slow the progression of
renal disease.
Information about the incidence of renal diseases or
risk factors for CKD in indigenous groups in Venezuela is
scarce. In a recent report, Herrera and Rodriguez-Iturbe
[8] showed that the incidence of ESRD in Goajiro Indians
was 220 pmp, 1.7 times higher than the estimate for the
country [8]. Although possible risk factors associated with
increased incidence of CKD in indigenous people have
not been clearly established, the authors suggest that a
combination of high rates of poststreptococcal glomeru-
lonephritis and a lower nephron endowment may be re-
sponsible [8]. Indeed, the incidence of poststreptococcal
glomerulonephritis was nearly twice that in other regions
of the state; and low birth weight, a condition presumed
associated with increased risk of CKD, was 23%.
The epidemiologic information about CKD and risk
factors in other Indian tribes in Venezuela is even more
limited. In fact, most of the information concerning mor-
bidity is categorized by districts and no differentiation
between Indians and the rest of the population is made
in the reports, thus increasing the difficulty of obtaining
reliable data. This is particularly striking in ethnic groups
living in Bolivar and Amazonas States, a vast region com-
prising 41% of the country. The few reports from the
Yanomamis, a tribe whose traditional lifestyle remains
relatively unaltered, indicate that the incidence of hyper-
tension is practically absent, a finding that is associated
with very low salt intake by these people [9–11].
Because most indigenous communities in this country
are isolated in remote areas and are faced with limited
communication with and transportation to urban areas,
health care is provided primarily through a network of
ambulatory centers of the public regional and national
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Table 1. Blood pressure in 4 indigenous groups in Bolivar State,
Venezuela
Ethnic group Number Age Systolic BP Diastolic BP
Pemon 63 33.6 ± 13 113 ± 11.7a 71 ± 8.6
Piaroa 100 33.5 ± 15.5 111 ± 13.5b 67 ± 9
Yekuana 70 31.9 ± 17.1 95.3 ± 7.9 63.5 ± 6.8
Sanema 67 29.6 ± 12.7 97.5 ± 18.7 62.5 ± 13
BP, blood pressure.
aPemon vs. Piaroa P < 0.001; Pemon vs. Sanema P < 0.001; Pemon vs. Yekuana
P < 0.001.
bPiaroa vs. Yekuana P < 0.0001; Piaroa vs. Sanema P < 0.01.
health system, and special programs from nonprofit civil
organizations. One of these organizations, Civil Organi-
zation for the Control of Endemic Diseases and Health
Assistance to the Indigenous, has developed a special pro-
gram to provide primary care and minimize the impact
of endemic diseases (malaria, tuberculosis leishmaniasis,
onchocercosis and yellow fever, among others) in indige-
nous communities of Bolivar State. The disease burden
among these communities includes infectious and para-
sitic diseases (30%), whereas hypertension (2.5%) and
urinary infection (4%) were diagnosed rarely. Table 1
shows the blood pressure of a random sample of 300 in-
dividuals from 4 different indigenous ethnic groups eval-
uated by Control of Endemic Diseases and Health As-
sistance to the Indigenous teams on periodic visits to the
communities from 2000 to 2002. Although mean systolic
and diastolic blood pressures were normal in all 4 groups,
Pemon and Piaroa Indians showed significantly higher
levels compared with those from Yekuana and Sanema
Indians. Only 5 individuals, 4 Pemon and 1 Piaroa, showed
a blood pressure equal to or higher than 140/90 mm Hg.
Because these 2 tribes have more contact with urban ar-
eas than the other two, it could be speculated that diet,
particularly salt ingestion, and other external factors as-
sociated with acculturation may be responsible in part
for higher blood pressures in these ethnic groups. Further
studies should be performed to determine the prevalence
of hypertension and factors associated with higher blood
pressures in these ethnic groups. Apart from the few cases
with moderate hypertension, the only other risk factor for
renal disease was urinary tract infection. However, it is
possible that renal disease may be underestimated due,
in part, to the inability to perform laboratory tests such
as blood glucose, serum creatinine, and even urinalysis.
It is evident that there are unmet needs of primary care
in the region.
The state of Amazonas has the greatest percentage of
Indians in Venezuela (40%). With a total of 70,464 inhab-
itants, the state has the lowest population density of the
country (0.4 inhabitants per square kilometer), 89% of
which is in the capital. The state has the second highest
infant mortality rate (32.4% vs. 19.25% for the country as
a whole) and high mortality due to infectious and para-
sitic diseases (21.4%). Diabetes, in persons older than 25
years, and renal diseases listed in the registry as “nephri-
tis and nephrosis” account for 2.4% and 1.2% of deaths,
respectively. The relative proportion of these causes of
mortality in the Indian population is not known. How-
ever, as discussed below, it seems probable that the in-
cidence of type 2 diabetes and CKD is higher in Indians
than in the rest of the population of the state.
ACCESS AND COVERAGE OF RRT
Dialysis
Although access to health care in Venezuela is univer-
sal and the total number of patients on RRT has increased
progressively in recent years [12, 13], there are still dis-
parities in coverage among different regions. According
to the Venezuelan Registry of Dialysis and Transplanta-
tion [8], the total prevalent ESRD population on dialysis
has increased progressively, reaching a maximum of 292
pmp by year 2003. However, this is still only 72.25% of
the expected 400 pmp estimated by the Latin American
Society of Nephrology and Hypertension for our region.
Close to 90% of the cases are covered by social security
and the remaining 10% by the Ministry of Health. Virtu-
ally no patients are covered by private health insurances.
The expected coverage is difficult to achieve for the coun-
try as a whole, because many rural areas or regions are
relatively inaccessible and have no chronic dialysis cen-
ters [13]. Some areas have high rates of unemployment or
informal employment; therefore, they have less coverage
by the social security system (Fig. 1). As a consequence,
the disparities in access to RRT in Venezuela depend, in
great measure, on specific characteristics of the different
regions of the country rather than ethnicity per se. For
example, in large and industrialized cities the prevalence
rate of patients on RRT is close to the expected 400 pmp,
whereas in less-populated and/or poorer regions it may
be less than 50 pmp (Fig. 1). Apart from these character-
istics, approximately 60% of the states have a coverage
level equivalent to 60% of the national average.
In Venezuela, it has been estimated that 3234 new cases
per year (133 pmp) require RRT, [11] but only 46% are
admitted to the different modalities of dialysis. Yet, it
should be emphasized that the incidence of ESRD in the
country is underreported because of the low number of
dialysis centers and prevailing coverage by the social se-
curity system. Therefore, the problem of disparities in
RRT in Venezuela goes beyond racial minorities; it af-
fects a high proportion of the population, particularly in
rural and less-developed as well as socioeconomically de-
prived areas. In an effort to reduce the impact of these
disparities, national public policies implemented include
increasing the proportional allocation of funds from the
Ministry of Health to the dialysis program, such as for the
purchase of pharmaceutical supplies for the treatment of
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Fig. 1. Prevalent patients in dialysis in Venezuela in 2003. The dotted horizontal line represents average prevalence in the country.
Table 2. Main causes of admission of patients with ESRD to dialysis
in Puerto Ayacucho, Venezuela, during a 2-year period from January
2001 to December 2002
Diagnosis ESRD % Indigenous %
Diabetes mellitus, type 2 13 65 8 61.15
Hypertension 2 10 8a –
Glomerulonephritis 1 5 – –
SLE 1 5 – –
Undetermined 3 15 – –
Total 20 100 8 61.15
Abbreviations are: ESRD, end-stage renal disease; SLE, systemic lupus
erythematosus.
aAll indigenous patients had type 2 diabetes and hypertension.
anemia, especially in regions not adequately covered by
social security.
To assess the prevalence of ESRD among Indians in
the 2 states (Bolivar and Amazonas, respectively) with
the second largest Indian population, we examined hos-
pital records from the University Hospital Ruiz y Paez
of Ciudad Bolivar and Hospital Jose Gregorio Hernan-
dez of Puerto Ayacucho, the main referral centers. The
proportion of Indians with ESRD admitted to the dialy-
sis unit of the first of these hospitals during a period of
3 years from January 2000 to December 2002 was 3.6%.
In contrast, at the second hospital, CKD was detected in
30 out of 135 patients referred for nephrology consulta-
tion (Table 2). Twenty had ESRD requiring RRT. Type
2 diabetes was the cause of ESRD in 12 of the patients,
of which 8 (66.6%) were Indian from at least 4 different
ethnic groups (4 Jivi, 1 Guahibo, 1 Ibaniva, 1 Bare, 2 un-
determined). These and other preliminary data suggest
that the incidence of diabetes in this ESRD population is
more than twice that of the country as a whole. However,
additional studies are needed to determine the possible
factors involved in the apparently increasing incidence of
diabetes and CKD in these minority groups.
It is difficult to estimate the real incidence and preva-
lence of ESRD in these minority groups, because many
of them do not seek specialized medical care or aban-
don dialysis early due to socioeconomic, cultural, and re-
ligious factors. Other factors include extreme distances
between specialized centers and their communities. RRT
is available only in main urban and industrialized areas,
leaving a large portion of the country without such facil-
ities. Thus, as shown in Figure 1, the prevalence rates of
RRT in the 2 states were 155.8 pmp and 127 pmp, respec-
tively, which was considerably lower than the average rate
for the country as a whole.
Renal transplantation
The number of renal transplantations in Venezuela has
increased in the last several years [13], reaching a max-
imum of 208 per year, and a coverage rate of 8.2 pmp
in 2002. However, this rate is clearly insufficient to meet
the demand and constitutes approximately 10% of the
total number of patients on dialysis. The proportion of
transplants from deceased donors has increased steadily
during the last few years, reaching 62% of the total in
2002.
All transplant centers in Venezuela require accredita-
tion by the Ministry of Health. According to program
policy, all patients with ESRD are entitled to deceased
donor renal transplant, provided they are registered and
comply with the requisites of the national waiting list.
Children and highly sensitized patients have priority for
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the allocation of kidneys from deceased donors. Living
related donors are allowed up to the fourth degree of
consanguinity. Nonrelated living donors are not allowed
by law, except in the case of a spouse, after approval by
a special commission. Therefore, at least theoretically,
there should be no disparity in the access to and alloca-
tion of organs for transplantation in Venezuela. However,
factors such as delay in the evaluation for placement on
the waiting list and costs of pretransplant evaluation may
have a disproportionate impact on poorer patients not
covered by social security or other public or private re-
sources.
In order to expand coverage of the transplant pro-
grams, the Ministry of Health established collabora-
tion with the nongovernmental National Organization of
Transplant of Venezuela to establish 2 important initia-
tives that will likely result in an increase in the number
of transplants. The first includes placing local transplant
coordinators in charge of the logistics of donor identifica-
tion, organ procurement, and allocation [13]. The second
involves the creation of a special fund for organ transplan-
tation within the budget of the Ministry of Health [13].
Through this fund, a fixed amount of money is allocated
to the center for each transplant performed. Preliminary
results suggest that these 2 initiatives will likely increase
the number of transplants in the country.
FUTURE TRENDS IN PUBLIC POLICIES
Although access to health care in Venezuela is univer-
sal, there are a limited number of facilities and disparity in
the access to RRT largely as a result of inadequate fund-
ing. It is also evident that, with current rising trends of the
incidence of ESRD and costs of health care, the already
stressed system will be further challenged. The long-term
goal of complete RRT coverage will become increasingly
out of reach. The major causes of ESRD in Venezuela are
diabetes and hypertension. Data from recent epidemio-
logic and clinical studies suggest that progression of renal
disease associated with these conditions could be slowed
through pharmacologic and nonpharmacologic measures
[14, 15], and at relatively low cost.
The Ministry of Health has recently revised its policy
on management of renal diseases in the following 4 cate-
gories: 1. Prevention by means of early detection of risk
factors and referral to multidisciplinary health teams, as
well as promotion of health habits in the community, par-
ticularly in high-risk groups. 2. Prevention of progression
of renal disease by pharmacologic and nonpharmacologic
means. 3. An increase in the rate of coverage and reduc-
tion of disparities in access to dialysis. 4. An increase in
the rates of renal transplantation through aggressive pro-
grams of organ procurement and allocation at the trans-
plant centers.
However, the projected increase in the number of pa-
tients with ESRD requiring RRT will continue to have
a serious impact on the health care system. Therefore,
the successful implementation of these policies will re-
quire collaboration between nephrologists and health
care planners to achieve a balance with other urgent pri-
orities of the National Health System and, as recently sug-
gested by Schieppatti [15], involvement of international
agencies, such as the World Health Organization and the
Pan American Health Organization.
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